AANP FNP CERTIFICATION COMPREHENSIVE
PRACTICE EXAM LATEST UPDATED ACTUAL FINAL
EXAM WITH ALL POSSIBLE MOST TESTED 100
PRACTICE QUESTIONS AND 100% CORRECT VERIFIED
ANSWERS FULLY SOLVED WITH DETAILED
RATIONALES PLUS EXPERT ANSWER KEY 2026-2027
FINAL EXAM UPDATED VERSION 100% GUARANTEED
PASS MOST RECENT!!!
1. A 45-year-old female presents with fatigue,
weight gain, and cold intolerance. TSH is 12.5
mIU/L (normal 0.4–4.0). What is the most
appropriate initial treatment?
A. Levothyroxine 50 mcg daily
B. Levothyroxine 25 mcg daily
C. Liothyronine 25 mcg daily
D. Observation with repeat TSH in 6 weeks
Correct Answer: B
Rationale: For overt hypothyroidism, start
levothyroxine at 25–50 mcg daily in adults; lower
doses (25 mcg) are preferred in patients over 50 or
,with cardiac risk. Starting at 50 mcg may be
appropriate for younger healthy patients, but the
safer initial dose here is 25 mcg. Liothyronine is not
first-line. Observation is not indicated for
symptomatic hypothyroidism.
2. A 28-year-old male with hypertension is
prescribed lisinopril. What laboratory test should
be checked within 1–2 weeks of initiation?
A. Serum potassium and creatinine
B. Liver function tests
C. Complete blood count
D. Urinalysis
Correct Answer: A
Rationale: ACE inhibitors can cause hyperkalemia
and acute kidney injury, so serum potassium and
creatinine should be checked soon after starting
therapy. Liver function, CBC, and urinalysis are not
routinely required for monitoring.
3. A 60-year-old male with type 2 diabetes has a
hemoglobin A1c of 8.5% on metformin 1000 mg
BID. What is the next best step?
,A. Add a GLP-1 receptor agonist
B. Add insulin glargine
C. Add a sulfonylurea
D. Increase metformin to 2000 mg BID
Correct Answer: A
Rationale: In patients with type 2 diabetes and A1c
> 8% on metformin, adding a GLP-1 agonist is
preferred due to weight loss and cardiovascular
benefits, especially in patients with obesity or CVD.
Sulfonylureas increase hypoglycemia risk. Insulin is
usually third-line. Max metformin dose is 2000
mg/day, but adding an agent is more effective.
4. A 52-year-old female presents with hot flashes
and night sweats for 6 months. She has a history of
breast cancer. What is the safest non-hormonal
therapy?
A. Paroxetine
B. Gabapentin
C. Venlafaxine
D. All of the above are options
Correct Answer: D
Rationale: Non-hormonal options for vasomotor
, symptoms in breast cancer survivors include SSRIs
(paroxetine, venlafaxine) and gabapentin. All are
considered safe and effective, though paroxetine
has CYP2D6 interactions with tamoxifen, so
venlafaxine or gabapentin may be preferred. The
question asks for "safest non-hormonal therapy"
and all are acceptable, so D is correct.
5. A 30-year-old female with dysuria and frequency
has a urine dipstick positive for nitrites and
leukocyte esterase. She is not pregnant and has no
comorbidities. Which antibiotic is first-line?
A. Nitrofurantoin 100 mg BID for 5 days
B. Ciprofloxacin 250 mg BID for 3 days
C. Amoxicillin-clavulanate 875/125 mg BID for 7
days
D. Trimethoprim-sulfamethoxazole 160/800 mg BID
for 3 days
Correct Answer: A
Rationale: For uncomplicated UTI in non-pregnant
women, nitrofurantoin (5 days) or fosfomycin
(single dose) are first-line due to low resistance.
TMP-SMX is acceptable only if resistance < 20%.
PRACTICE EXAM LATEST UPDATED ACTUAL FINAL
EXAM WITH ALL POSSIBLE MOST TESTED 100
PRACTICE QUESTIONS AND 100% CORRECT VERIFIED
ANSWERS FULLY SOLVED WITH DETAILED
RATIONALES PLUS EXPERT ANSWER KEY 2026-2027
FINAL EXAM UPDATED VERSION 100% GUARANTEED
PASS MOST RECENT!!!
1. A 45-year-old female presents with fatigue,
weight gain, and cold intolerance. TSH is 12.5
mIU/L (normal 0.4–4.0). What is the most
appropriate initial treatment?
A. Levothyroxine 50 mcg daily
B. Levothyroxine 25 mcg daily
C. Liothyronine 25 mcg daily
D. Observation with repeat TSH in 6 weeks
Correct Answer: B
Rationale: For overt hypothyroidism, start
levothyroxine at 25–50 mcg daily in adults; lower
doses (25 mcg) are preferred in patients over 50 or
,with cardiac risk. Starting at 50 mcg may be
appropriate for younger healthy patients, but the
safer initial dose here is 25 mcg. Liothyronine is not
first-line. Observation is not indicated for
symptomatic hypothyroidism.
2. A 28-year-old male with hypertension is
prescribed lisinopril. What laboratory test should
be checked within 1–2 weeks of initiation?
A. Serum potassium and creatinine
B. Liver function tests
C. Complete blood count
D. Urinalysis
Correct Answer: A
Rationale: ACE inhibitors can cause hyperkalemia
and acute kidney injury, so serum potassium and
creatinine should be checked soon after starting
therapy. Liver function, CBC, and urinalysis are not
routinely required for monitoring.
3. A 60-year-old male with type 2 diabetes has a
hemoglobin A1c of 8.5% on metformin 1000 mg
BID. What is the next best step?
,A. Add a GLP-1 receptor agonist
B. Add insulin glargine
C. Add a sulfonylurea
D. Increase metformin to 2000 mg BID
Correct Answer: A
Rationale: In patients with type 2 diabetes and A1c
> 8% on metformin, adding a GLP-1 agonist is
preferred due to weight loss and cardiovascular
benefits, especially in patients with obesity or CVD.
Sulfonylureas increase hypoglycemia risk. Insulin is
usually third-line. Max metformin dose is 2000
mg/day, but adding an agent is more effective.
4. A 52-year-old female presents with hot flashes
and night sweats for 6 months. She has a history of
breast cancer. What is the safest non-hormonal
therapy?
A. Paroxetine
B. Gabapentin
C. Venlafaxine
D. All of the above are options
Correct Answer: D
Rationale: Non-hormonal options for vasomotor
, symptoms in breast cancer survivors include SSRIs
(paroxetine, venlafaxine) and gabapentin. All are
considered safe and effective, though paroxetine
has CYP2D6 interactions with tamoxifen, so
venlafaxine or gabapentin may be preferred. The
question asks for "safest non-hormonal therapy"
and all are acceptable, so D is correct.
5. A 30-year-old female with dysuria and frequency
has a urine dipstick positive for nitrites and
leukocyte esterase. She is not pregnant and has no
comorbidities. Which antibiotic is first-line?
A. Nitrofurantoin 100 mg BID for 5 days
B. Ciprofloxacin 250 mg BID for 3 days
C. Amoxicillin-clavulanate 875/125 mg BID for 7
days
D. Trimethoprim-sulfamethoxazole 160/800 mg BID
for 3 days
Correct Answer: A
Rationale: For uncomplicated UTI in non-pregnant
women, nitrofurantoin (5 days) or fosfomycin
(single dose) are first-line due to low resistance.
TMP-SMX is acceptable only if resistance < 20%.
